This notion has become controversial again after a minor OS prolongation with radiotherapy plus temozolomide versus radiotherapy alone was observed in elderly patients with glioblastomas lacking MGMT promoter methylation94 and with the negative outcome of the CheckMate 498 trial100. Here, MGMT is linked to glioblastoma.